Binding of Mucin by E. coli from Human Gut


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Тек жазылушылар үшін

Аннотация

Cells of E. coli isolates from the gut of healthy volunteers (N=5) and patients with Crohn’s disease (N=5) and laboratory E. coli strain DH5α bound mucin in vitro in similar amounts ranging from 0.02 to 0.12 mg/mg of bacterial dry weight. Binding was evaluated by the decrease in optical absorption of mucin solution at 214 nm after incubation with bacteria. Detailed analysis of mucin binding by one of isolates showed that during incubation of 0.09 mg/ml bacteria in 0.15 M NaCl containing 0.1 mg/ml mucin at 25oC, maximum binding was reached in 30 min, while in the presence of 14 mM α-methyl mannoside, mucin binding decreased by 46% (p<0.05). Confocal microscopy revealed intensive binding of FITC-labeled mucin to the surface of a small number of bacterial cells. Mucin binding did not significantly affect zeta potential of bacteria and their energetic status assessed by ATP content; at the same time, ATP content in the extracellular environment slightly increased.

Авторлар туралы

T. Vakhrusheva

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Ресей, Moscow

Yu. Baikova

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Ресей, Moscow

N. Balabushevich

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Ресей, Moscow

S. Gusev

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Ресей, Moscow

G. Lomakina

Faculty of Chemistry, M. V. Lomonosov Moscow State University

Email: lemik2007@yandex.ru
Ресей, Moscow

E. Sholina

Faculty of Chemistry, M. V. Lomonosov Moscow State University

Email: lemik2007@yandex.ru
Ресей, Moscow

M. Moshkovskaya

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Ресей, Moscow

P. Shcherbakov

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Ресей, Moscow

O. Pobeguts

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
Ресей, Moscow

E. Mikhal’chik

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Хат алмасуға жауапты Автор.
Email: lemik2007@yandex.ru
Ресей, Moscow


© Springer Science+Business Media, LLC, part of Springer Nature, 2018

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>